Static Chart Pasithea Therapeutics Corp.

Equities

Delayed Nasdaq Other stock markets 08:50:46 15/05/2024 pm IST			5-day change	1st Jan Change
6.65 ^USD	0.00%		-5.67%	-10.14%

24/04	Pasithea Therapeutics Corp. Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers	CI
29/03	Pasithea Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Duration

Period